共 46 条
[2]
Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents
[J].
GENES CHROMOSOMES & CANCER,
2001, 31 (01)
:33-41
[6]
Bloomfield CD, 1997, CANCER-AM CANCER SOC, V80, P2191
[7]
Bloomfield CD, 1998, CANCER RES, V58, P4173
[10]
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2001, 19 (05)
:1405-1413